OBJECTIVES: To examine the extent to which receipt of recommended monitoring of diabetes mellitus (DM) differed for participants with and without comorbid dementia, as well as the effect of other comorbidities on monitoring of DM in individuals with comorbid dementia. DESIGN: Retrospective cohort study. SETTING: Secondary analysis of 2005/2006 claims and enrollment data for a 5% national random sample of Medicare beneficiaries. PARTICIPANTS: Two hundred eighty-eight thousand eight hundred five Medicare fee-for-service beneficiaries with a diagnosis of DM before 2006, 44,717 (16%) of whom had evidence of comorbid dementia in claims. MEASUREMENTS: Established algorithms were used to determine whether patients received at least one glycosylated hemoglobin (HbA1c) test, one low-density lipoprotein cholesterol (LDL-C) test, and one annual eye examination in 2006 and to construct variables representing comorbidities common in DM, sociodemographic characteristics, and patterns of healthcare utilization. RESULTS: In unadjusted and fully adjusted models, the presence of dementia reduced the likelihood of receiving HbA1c tests, LDL-C tests, and eye examinations, with effects being smallest for HbA1c tests. The effects of other comorbidities on DM monitoring in participants with dementia varied according to the nature of the comorbidity and the specific test. CONCLUSION: Dementia reduces the likelihood that individuals with DM will receive recommended annual monitoring for DM. More research is needed to understand reasons for lower monitoring in this subgroup and how this affects functioning, adverse events, and quality of life.
OBJECTIVES: To examine the extent to which receipt of recommended monitoring of diabetes mellitus (DM) differed for participants with and without comorbid dementia, as well as the effect of other comorbidities on monitoring of DM in individuals with comorbid dementia. DESIGN: Retrospective cohort study. SETTING: Secondary analysis of 2005/2006 claims and enrollment data for a 5% national random sample of Medicare beneficiaries. PARTICIPANTS: Two hundred eighty-eight thousand eight hundred five Medicare fee-for-service beneficiaries with a diagnosis of DM before 2006, 44,717 (16%) of whom had evidence of comorbid dementia in claims. MEASUREMENTS: Established algorithms were used to determine whether patients received at least one glycosylated hemoglobin (HbA1c) test, one low-density lipoprotein cholesterol (LDL-C) test, and one annual eye examination in 2006 and to construct variables representing comorbidities common in DM, sociodemographic characteristics, and patterns of healthcare utilization. RESULTS: In unadjusted and fully adjusted models, the presence of dementia reduced the likelihood of receiving HbA1c tests, LDL-C tests, and eye examinations, with effects being smallest for HbA1c tests. The effects of other comorbidities on DM monitoring in participants with dementia varied according to the nature of the comorbidity and the specific test. CONCLUSION:Dementia reduces the likelihood that individuals with DM will receive recommended annual monitoring for DM. More research is needed to understand reasons for lower monitoring in this subgroup and how this affects functioning, adverse events, and quality of life.
Authors: Matthew K McNabney; Naushira Pandya; Cletus Iwuagwu; Meenakshi Patel; Paul Katz; Vicki James; Barbara Calabrese; Larry Lawhorne Journal: J Am Med Dir Assoc Date: 2005-07-22 Impact factor: 4.669
Authors: Lillian C Min; Neil S Wenger; Constance Fung; John T Chang; David A Ganz; Takahiro Higashi; Caren J Kamberg; Catherine H MacLean; Carol P Roth; David H Solomon; Roy T Young; David B Reuben Journal: Med Care Date: 2007-06 Impact factor: 2.983
Authors: Eve A Kerr; Michele Heisler; Sarah L Krein; Mohammed Kabeto; Kenneth M Langa; David Weir; John D Piette Journal: J Gen Intern Med Date: 2007-07-24 Impact factor: 5.128
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004
Authors: Elizabeth M Magnan; Mari Palta; Heather M Johnson; Christie M Bartels; Jessica R Schumacher; Maureen A Smith Journal: J Diabetes Complications Date: 2014-10-13 Impact factor: 2.852
Authors: Vishal Bali; Satabdi Chatterjee; Michael L Johnson; Hua Chen; Ryan M Carnahan; Rajender R Aparasu Journal: J Comp Eff Res Date: 2016-07-18 Impact factor: 1.744
Authors: Christie M Bartels; Jessica M Saucier; Carolyn T Thorpe; Amy J H Kind; Nancy Pandhi; Karen E Hansen; Maureen A Smith Journal: Arthritis Res Ther Date: 2012-07-18 Impact factor: 5.156
Authors: Maria Panagioti; Jonathan Stokes; Aneez Esmail; Peter Coventry; Sudeh Cheraghi-Sohi; Rahul Alam; Peter Bower Journal: PLoS One Date: 2015-08-28 Impact factor: 3.240
Authors: Nicole R Fowler; Amber E Barnato; Howard B Degenholtz; Angela M Curcio; James T Becker; Lewis H Kuller; Oscar L Lopez Journal: J Aging Res Date: 2014-02-25
Authors: Frances Bunn; Anne-Marie Burn; Claire Goodman; Greta Rait; Sam Norton; Louise Robinson; Johan Schoeman; Carol Brayne Journal: BMC Med Date: 2014-10-31 Impact factor: 8.775
Authors: Jeremie Lebrec; Haya Ascher-Svanum; Yun-Fei Chen; Catherine Reed; Kristin Kahle-Wrobleski; Ann Marie Hake; Joel Raskin; Ebrahim Naderali; Dara Schuster; Robert J Heine; David M Kendall Journal: BMC Geriatr Date: 2016-05-03 Impact factor: 3.921